Effect of human urotensin-II infusion on hemodynamics and cardiac function

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 2, 2003, Pages 125-128

  Hassan, Ghada S ^a   Chouiali, Fazila ^a   Saito, Takayuki ^a   Hu, Fu ^a   Douglas, Stephen A ^b   Ao, Zhaohui ^b   Willette, Robert N ^b   Ohlstein, Eliot H ^b   Giaid, Adel ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Heart; Infusion; Rat; Urotensin II

Indexed keywords

UROTENSIN II;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOSE RESPONSE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE CONTRACTILITY; HEMODYNAMICS; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMIC PROCESSES; HUMANS; INFUSION PUMPS; INJECTIONS, INTRAVENOUS; MYOCARDIAL CONTRACTION; RATS; UROTENSINS; VENTRICULAR FUNCTION, LEFT;

EID: 0037306455     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y03-004     Document Type: Conference Paper

References (21)

1. Ames, R.S., Sarau, H.M., Chambers, J.K., Willette, R.N., Aiyar, N.V., Romanic, A.M., Louden, C.S., Foley, J.J., Sauermelch, C.F., Coatney, R.W., Ao, Z., Disa, J., Holmes, S.D., Stadel, J.M., Martin, J.D., Liu, W.S., Glover, G.I., Wilson, S., McNulty, D.E., Ellis, C.E., Elshourbagy, N.A., Shabon, U., Trill, J.J., Hay, D.W., and Douglas, S.A., 1999. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature (London), 401(6750): 282-286.
2. Bern, H.A., Pearson, D., Larson, B.A., and Nishioka, R.S. 1985. Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes. Rec. Prog. Horm. Res. 41: 533-552.
3. Bottrill, F.E., Douglas, S.A., Hiley, C.R., and White, R. 2000. Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. Br. J. Pharmacol. 130: 1865-1870.
4. Coulouarn, Y., Lihrmann, I., Jegou, S., Anouar, Y., Tostivint, H., Beauvillain, J.C., Conlon, J.M., Bern, H.A., and Vaudry, H. 1998. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc. Natl. Acad. Sci. U.S.A. 95: 15 803 - 15 888.
5. Coulouarn, Y., Jegou, S., Tostivint, H., Vaudry, H., and Lihrmann, I. 1999. Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett. 457: 28-32.
6. Douglas, S.A., Ashton, D.J., Sauermelch, C.F., Coatney, R.W., Ohlstein, D.H., Ruffolo, M.R., Ohlstein, E.H., Aiyar, N.V., and Willette, R.N. 2000. Human urotensin-II is a potent vasoactive peptide: pharmacological characterization in the rat, mouse, dog and primate. J. Cardiovasc. Pharmacol. 36(5 Suppl 1): S163-S166.
7. Douglas S.A., Tayara, L., Ohlstein, E.H., Halaw, N., and Giaid, A. 2002. Congestive heart failure and expression of myocardial urotensin II. Lancet, 359: 1990-1997.
8. Gibson, A., Wallace, P., and Bern, H.A. 1986. Cardiovascular effects of urotensin II in anesthetized and pithed rats. Gen. Comp. Endocrinol. 64: 435-439.
9. Gibson, A., Conyers, S., and Bern, H.A. 1988. The influence of urotensin II on calcium flux in rat aorta. J. Pharm. Pharmacol. 40: 893-895.
10. Itoh, H., Itoh, Y., Rivier, J., and Lederis, K. 1987. Contraction of major artery segments of rat by fish neuropeptide urotensin II. Am. J. Physiol. 252: R361-R366.
11. Katano, Y., Ishihata, A., Aita, T., Ogaki, T., and Horie, T. 2000. Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries. Eur. J. Pharmacol. 402: R5-R7.
12. Liu, Q., Pong, S.S., Zeng, Z., Zhang, Q., Howard, A.D., Williams, D.L. Jr, Davidoff, M., Wang, R., Austin, C.P., McDonald, T.P., Bai, C., George, S.R., Evans, J.F., and Caskey, C.T. 1999. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem. Biophys. Res. Commun. 266: 174-178.
13. Maguire, J.J., Kuc, R.E., and Davenport, A.P. 2000. Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br. J. Pharmacol. 131: 441-446.
14. Mori, M., Sugo, T., Abe, M., Shimomura, Y., Kurihara, M., Kitada, C., Kikuchi, K., Shintani, Y., Kurokawa, T., Onda, H., Nishimura, O., and Fujino, M. 1999. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem. Biophys. Res. Commun. 265: 123-129.
15. National Institutes of Health. 1985. Guide for the care and unse of laboratory animals. United States Department of Health and Human Services Publication 85-23, Washington, D.C.
16. Nothacker, H.P., Wang, Z., McNeill, A.M., Saito, Y., Merten, S., O'Dowd, B., Duckles, S.P., and Civelli, O. 1999. Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat. Cell Biol. 1: 383-385.
17. Opgaard, O.S., Nothacker, H., Ehlert, F.J., and Krause, D.N. 2000. Human urotensin II mediates vasoconstriction via an increase in inositol phosphates. Eur. J. Pharmacol. 406: 265-271.
18. Pollard, T.J. 2000. The acute myocardial infarction. Prim. Care, 27: 631-649.
19. Russell, F.D., Molenaar, P., and O'Brien, D.M. 2001. Cardiostimulant effects of urotensin-II in human heart in vitro. Br. J. Pharmacol. 132: 5-9.
20. Stirrat, A., Gallagher, M., Douglas, S.A., Ohlstein, E.H., Berry, C., Kirk, A., Richardson, M., and MacLean, M.R. 2001. Potent vasodilator responses to human urotensin-II in human pulmonary and abdominal resistance arteries. Am. J. Physiol. 280: H925-H928.
21. Tayara, L., Fahas, L., Saito, T., Shennib, H., Fu, H., Doulas, S.A., Ao. Z., Willette, R.N., Ohlstein, E.H., and Giaid A. 2003. Upregulation of urotensin-II expression in the myocardium of rats with myocardial infarction: effect of human U-II infusion on hemodynamics and cardiac function. Can. J. Physiol. Pharmacol. 81: In press.